Literature DB >> 4068909

Effect of moderate to very low fat defined formula diets on serum lipids in healthy subjects.

J T Snook, J P DeLany, V M Vivian.   

Abstract

Serum total cholesterol, high density lipoprotein (HDL) cholesterol, and triglyceride levels were studied in healthy male and female subjects consuming for one-week periods a diet of conventional food (CF) providing 42% of energy as fat, principally butter fat, and then in random order nutritionally complete, defined formula diets of moderate (32%) to very low (1%) fat content. Compared to CF, the formula with 32% of energy as corn oil lowered serum cholesterol by 25% and the ratio of total to HDL-cholesterol by 13%. Low (9%) and very low (1-3%) fat formulas reduced HDL-cholesterol by as much as 40%, raised the total:HDL-cholesterol ratio by about 20% and raised serum triglyceride levels by as much as 100%. When low and very low fat formulas were ingested for three weeks, these effects persisted although maximal responses occurred during the first week. These results demonstrated that a moderate fat formula diet with a high P/S ratio had a more favorable effect on serum lipid levels than various low fat formulas. Low fat conventional food diets should be studied in long-term controlled metabolic experiments before such diets are recommended to the general population for coronary heart disease or cancer prevention.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4068909     DOI: 10.1007/BF02534406

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  18 in total

1.  Correlations between intravenous fat tolerance and serum lipoproteins in normal and atherosclerotic subjects.

Authors:  M Ericsson; S Rössner
Journal:  Atherosclerosis       Date:  1979-05       Impact factor: 5.162

2.  Metabolic regulation of plasma high density lipoprotein concentrations.

Authors:  E A Nikkila
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

3.  Diet and plasma lipids--a reappraisal.

Authors:  A S Truswell
Journal:  Am J Clin Nutr       Date:  1978-06       Impact factor: 7.045

Review 4.  Regulation of high density lipoprotein levels.

Authors:  R M Krauss
Journal:  Med Clin North Am       Date:  1982-03       Impact factor: 5.456

5.  Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets.

Authors:  J H Brussaard; M B Katan; P H Groot; L M Havekes; J G Hautvast
Journal:  Atherosclerosis       Date:  1982-04       Impact factor: 5.162

Review 6.  Hypertriglyceridemia: mechanisms, clinical significance, and treatment.

Authors:  S M Grundy
Journal:  Med Clin North Am       Date:  1982-03       Impact factor: 5.456

7.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

8.  High density lipoprotein metabolism in man.

Authors:  C B Blum; R I Levy; S Eisenberg; M Hall; R H Goebel; M Berman
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat.

Authors:  A Geliebter; N Torbay; E F Bracco; S A Hashim; T B Van Itallie
Journal:  Am J Clin Nutr       Date:  1983-01       Impact factor: 7.045

10.  Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.

Authors:  P Magill; S N Rao; N E Miller; A Nicoll; J Brunzell; J St Hilaire; B Lewis
Journal:  Eur J Clin Invest       Date:  1982-04       Impact factor: 4.686

View more
  1 in total

1.  Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid.

Authors:  Y H Tsai; S Park; J Kovacic; J T Snook
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.